Japanese regulators just quietly gave researchers there a historic OK to generate human embryos from stem cells in the lab — no ovaries or testes needed. Scientists in Japan and around the world ...

Celebrity health Kim Kardashian travels to Mexico for treatment: Here's why she couldn't do her stem cell therapy in the U.S ...

Biostar's Angel Stem Cell Therapy Approved for Clinical Use in Japan; Treatments Begin August 7th LOS ANGELES, CA / ACCESS Newswire / August 8, 2025 / Biostar Stem Cell Technology Research Institute, ...

STEM gears up for Q2 earnings as software momentum, cost cuts, and margin shifts drive performance trends.

Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients ...

In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...

Lab grown models of embryos, made from clusters of stem cells, are getting increasingly complex. Ethicists, regulators and legal specialists are scrambling to keep up with the pace of research.

CINCINNATI — Five all-girls Catholic high schools in Cincinnati are making history after receiving a $2 million STEM education grant. The presidents of Mercy-McAuley, Mount Notre Dame, Saint ...

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic busulfan chemotherapy or radiation, a Phase I clinical trial has shown.

An antibody treatment successfully prepared patients for stem cell transplants without toxic chemotherapy or radiation.

If you want to know who really controls Stem, Inc. (NYSE:STEM), then you'll have to look at the makeup of its share registry. With 58% stake, individual investors possess the maximum shares in the ...